Nitric oxide alters metabolism in isolated alveolar type II cells

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 271, Issue 1 15-1, 1996, Pages

  Miles, P R ^a   Bowman, L ^b   Huffman, L ^b  

^a ALOSH   (United States)

^b NONE

Author keywords

adenosine 5' triphosphate; lung surfactant

Indexed keywords

ADENOSINE TRIPHOSPHATE; LUNG SURFACTANT; NITRIC OXIDE; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE;

ANIMAL CELL; ARTICLE; CELL ISOLATION; ENERGY METABOLISM; ENZYME ACTIVITY; ENZYME SUBSTRATE; LUNG ALVEOLUS CELL TYPE 2; LUNG FUNCTION; MITOCHONDRIAL MEMBRANE; NONHUMAN; OXYGEN CONSUMPTION; PRIORITY JOURNAL; RAT; SURFACE TENSION; TRANSCRIPTION REGULATION;

EID: 0029814828     PISSN: 10400605     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajplung.1996.271.1.l23     Document Type: Article

References (15)

1. Belvisi, M. G., C. C. Stretton, M. Yacoub, and P. J. Barnes. Nitric oxide is the endogenous neurotransmitter of bronchodilator nerves in human airways and guinea-pig airways. Eur. J. Pharmacol. 210: 221-222, 1992.
2. Chance, B., and G. R. Williams. The respiratory chain and oxidative phosphorylation. Adv. Enzymol. 17: 65-134, 1956.
3. Corbett, J. A., R. G. Tilton, K. Chang, K. S. Hasan, Y. Ido, J. L. Wang, M. A. Sweetland, J. R. Lancaster, J. R. Williamson, and M. L. McDaniel. Aminoguanidine, a novel inhibitor of nitric oxide formation, prevents diabetic vascular dysfunction. Diabetes 41: 552-556, 1992.
4. Crecelius, C. A., and W. J. Longmore. Phosphatidic acid phosphatase activity in subcellular fractions derived from adult type II cell pneumocytes in primary culture. Biochim. Biophys. Acta 750: 447-456, 1983.
5. Dinh-Xuan, A. T., T. W. Higenbottan, and C. A. Clelland. Impairment of endothelium-dependent pulmonary artery relaxation in chronic obstructive lung disease. N. Engl. J. Med. 324: 1539-1547, 1991.
6. 2+ on substrate utilization. Biochemistry 12: 1438-1445, 1973.
7. Folch, J., M. Lees, and G. H. Sloane Stanley. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem. 226: 496-509, 1957.
8. Gaston, B., J. M. Drazen, J. Loscalzo, and J. S. Stamler. The biology of nitrogen oxides in the airways. Am. Rev. Crit. Care Med. 149: 538-551, 1994.
9. 14N]nitrite in biological fluids. Anal. Biochem. 126: 131-138, 1982.
10. Griffiths, M. J. D., M. Messent, R. J. McAllister, and T. W. Evans. Aminoguanidine selectively inhibits inducible nitric oxide synthase. Br. J. Pharmacol. 110: 963-968, 1993.
11. Gutierrez, H. H., B. R. Pitt, M. Schwarz, S. C. Watkins, C. Lowenstein, I. Caniggia, P. Chumley, and B. A. Freeman. Pulmonary alveolar epithelial inducible NO synthase gene expression: regulation by inflammatory mediators. Am. J. Physiol. 268 (Lung Cell. Mol. Physiol. 12): L501-L508, 1995.
12. Haddad, I. Y., E. Barefield, C. Wilson, H. Cifuentes, S. Zu, P. Hu, and S. Matalon. Effects of nitric oxide on alveolar type II cell ATP and lipid synthesis (Abstract). Am. J. Respir. Crit. Care Med. 151: A647, 1995.
13. Haddad, I. Y., H. Ischiropoulos, B. A. Holm, J. S. Beckman, J. R. Baker, and S. Matalon. Mechanisms of peroxynitrite-induced injury to pulmonary surfactants. Am. J. Physiol. 265 (Lung Cell. Mol. Physiol. 9): L555-L564, 1993.
14. Hibbs, J. B., R. R. Taintor, Z. Vavrin, and E. M. Rachlin. Nitric oxide: a cytotoxic activated macrophage effector molecule. Biochem. Biophys. Res. Commun. 157: 87-94, 1988.
15. Hu, P., H. Ischiropoulos, J. S. Beckman, and S. Matalon. Peroxynitrite inhibition of oxygen consumption and sodium transport in alveolar type II cells. Am. J. Physiol. 266: (Lung Cell. Mol. Physiol. 10): L628-L634, 1994.